Listed

Graftech International Ltd: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 5, 2021 and accepted by EDGAR at May 5, 2021, 16:53 ET.

Share

Management's discussion and analysis

As filed, 39,210 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company

GrafTech is a leading manufacturer of graphite electrodes, the critical consumable for the electric arc furnace industry. We are the only graphite electrode producer that is substantially vertically integrated into petroleum needle coke, a key raw material for graphite electrodes. Vertical integration has allowed us to adopt a commercial strategy with long-term, fixed price, fixed volume, take-or-pay contracts ("LTAs") providing earnings stability and visibility. These contracts define volumes and prices, along with price-escalation mechanisms for inflation, and include significant termination payments (typically, 50% to 70% of remaining contracted revenue) and, in certain cases, parent guarantees and collateral arrangements to manage our customer credit risk.

The environmental and economic advantages of electric arc furnace steel production positions both that industry and the graphite electrode industry for continued long-term growth.

We believe GrafTech's leadership position, strong cash flows, and advantaged low cost structure and vertical integration are sustainable competitive advantages. Our services and solutions we provide will position our customers and us for a better future.

Commercial Update and Outlook

GrafTech reported solid results in the first quarter of 2021 with sales volumes of 37 thousand metric tons ("MT"), consisting of LTA volumes of 26 thousand MT at an average approximate price of $9,500 per MT and non-LTA volumes of 11 thousand MT at an average approximate price of $4,200 per MT.

The estimated shipments of graphite electrodes for the final two years of the initial term under our LTAs and for the years 2023 through 2024 remain unchanged from our prior estimate as follows:

2021 2022 2023 through 2024
Estimated LTA volume (thousands of metric tons) 98-108 95-105 35-45
Estimated LTA revenue (in millions) $925-$1,025 $910-$1,010 $350-$450(1)

(1) Includes expected termination fees from a few customers that have failed to meet certain obligations under their LTAs

Global steel market capacity utilization rates have continued to improve sequentially:

Q1 2021 Q4 2020 Q1 2020
Global (ex-China) capacity utilization rates 73% 72% 71%
U.S. steel market capacity utilization rates 77% 72% 79%

With the improved market demand, we expect sales volumes to increase through the balance of the year.

In February 2021, we provided an outlook on earnings per share and adjusted EBITDA for the first half of 2021. Due to better than expected first quarter results, we now anticipate first half earnings per share and adjusted EBITDA will decline by mid-single digits, on a percentage basis, compared to the first half of 2020. These estimates exclude the possibility of any Change in Control charges that could be triggered if and when Brookfield's ownership actually falls below 30%, or 35% with respect to certain equity awards. These charges could include a long-term incentive compensation ("LTIP") cash charge of $65 million to $75 million and non-cash accelerated equity compensation expense for certain equity awards of approximately $15.2 million.

Capital Structure and Capital Allocation

As of March 31, 2021, GrafTech had cash and cash equivalents of $96 million and total debt of approximately $1.3 billion.

Our 2021 capital expenditure range expectations are unchanged, between $55 and $65 million, and we continue to expect our primary use of cash to be debt repayment.

Key metrics used by management to measure performance

In addition to measures of financial performance presented in our Consolidated Financial Statements in accordance with U.S. generally accepted accounting principles ("GAAP"), we use certain other financial measures and operating metrics to analyze the performance of our company. The “non-GAAP” financial measures consist of EBITDA and adjusted EBITDA, which help us evaluate growth trends, establish budgets, assess operational efficiencies and evaluate our overall financial performance. The key operating metrics consist of sales volume, production volume, production capacity and capacity utilization.

Key financial measures

(in thousands)

For the Three Months Ended March 31, 2021 2020
Net sales $304,397 $318,646
Net income 98,799 122,268
EBITDA (1) 153,725 185,029
Adjusted EBITDA (1) 155,045 179,178

(1) Non-GAAP financial measures; see below for information and a reconciliation of EBITDA and adjusted EBITDA to net income, the most directly comparable financial measure calculated and presented in accordance with GAAP.

Key operating metrics

(in thousands, except price data)

For the Three Months Ended March 31, 2021 2020
Sales volume (MT)(1) 37 34
Production volume (MT)(2) 36 33
Production capacity excluding St. Marys (MT)(3)(4) 51 51
Capacity utilization excluding St. Marys (3)(5) 71% 65%
Total production capacity (MT)(4)(6) 58 58
Total capacity utilization(5)(6) 62% 57%

(1) Sales volume reflects only graphite electrodes manufactured by GrafTech.

(2) Production volume reflects graphite electrodes we produced during the period.

(3) In the first quarter of 2018, our St. Marys facility began graphitizing a limited amount of electrodes sourced from our Monterrey, Mexico facility.

(4) Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance outage. Actual production may vary.

(5) Capacity utilization reflects production volume as a percentage of production capacity.

(6) Includes graphite electrode facilities in Calais, France; Monterrey, Mexico; Pamplona, Spain and St. Marys, Pennsylvania.

Non-GAAP financial measures

In addition to providing results that are determined in accordance with generally accepted accounting principles in the United States (“GAAP”), we have provided certain financial measures that are not in accordance with GAAP. EBITDA and adjusted EBITDA are non‑GAAP financial measures. We define EBITDA, a non‑GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes, and depreciation and amortization. We define adjusted EBITDA as EBITDA adjusted for any pension and other post employment benefit ("OPEB") plan expenses or gains, initial and follow-on public offering and related expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar, related party Tax Receivable Agreement (as defined below) adjustments, stock-based compensation, and non‑cash fixed asset write‑offs. Adjusted EBITDA is the primary metric used by our management and our Board of Directors to establish budgets and operational goals for managing our business and evaluating our performance.

We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities. We also monitor the ratio of total debt to adjusted EBITDA, because we believe it is a useful and widely used way to assess our leverage.

Our use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:

  • adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
  • adjusted EBITDA does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
  • adjusted EBITDA does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
  • adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us;
  • adjusted EBITDA does not reflect expenses relating to our pension and OPEB plans;
  • adjusted EBITDA does not reflect the non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar;
  • adjusted EBITDA does not reflect initial and follow-on public offering and related expenses;
  • adjusted EBITDA does not reflect related party Tax Receivable Agreement adjustments;
  • adjusted EBITDA does not reflect stock-based compensation or the non‑cash write‑off of fixed assets; and
  • other companies, including companies in our industry, may calculate EBITDA and adjusted EBITDA differently, which reduces its usefulness as a comparative measure.

In evaluating EBITDA and adjusted EBITDA, you should be aware that in the future, we will incur expenses similar to the adjustments in the reconciliation below. Our presentations of EBITDA and adjusted EBITDA should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider EBITDA and adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP measures.

The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures:

(in thousands)

For the Three Months Ended March 31, 2021 2020
Net income $98,799 $122,268
Add:
Depreciation and amortization 16,539 14,284
Interest expense 22,167 25,672
Interest income (37) (1,141)
Income taxes 16,257 23,946
EBITDA 153,725 185,029
Adjustments:
Pension and OPEB plan expenses (1) 431 542
Initial and follow-on public offering and related expenses (2) 422 4
Non-cash gain on foreign currency remeasurement (3) (348) (3,461)
Stock-based compensation (4) 768 410
Related party Tax Receivable Agreement adjustment (5) 47 (3,346)
Adjusted EBITDA $155,045 $179,178

(1) Service and interest cost of our OPEB plans. Also includes a mark-to-market loss (gain) for plan assets as of December of each year.

(2) Legal, accounting, printing and registration fees associated with the initial and follow-on public offering and related expenses.

(3) Non-cash gains and losses from foreign currency remeasurement of non-operating assets and liabilities of our non-U.S. subsidiaries where the functional currency is the U.S. dollar.

(4) Non-cash expense for stock-based compensation grants.

(5) Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized.

Key operating metrics

In addition to measures of financial performance presented in accordance with GAAP, we use certain operating metrics to analyze the performance of our company. The key operating metrics consist of sales volume, production volume, production capacity and capacity utilization. These metrics align with management's assessment of our revenue performance and profit margin and will help investors understand the factors that drive our profitability.

Sales volume reflects only graphite electrodes manufactured by GrafTech. For a discussion of our revenue recognition policy, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Critical Accounting Policies-Revenue Recognition.” in our Annual Report on Form 10-K. Sales volume helps investors understand the factors that drive our net sales.

Production volume reflects graphite electrodes produced during the period. Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance downtime. Capacity utilization reflects production volume as a percentage of production capacity. Production volume, production capacity and capacity utilization help us understand the efficiency of our production, evaluate cost of sales and consider how to approach our contract initiative.

Results of Operations

The Three Months Ended March 31, 2021 Compared to the Three Months Ended March 31, 2020

The tables presented in our period-over-period comparisons summarize our Condensed Consolidated Statements of Operations and illustrate key financial indicators used to assess the consolidated financial results. Throughout our Management's Discussion and Analysis ("MD&A"), insignificant changes may be deemed not meaningful and are generally excluded from the discussion.

(Dollars in thousands)

For the Three Months Ended March 31, 2021 2020 Increase/ Decrease % Change
Net sales $304,397 $318,646 $(14,249) (4)%
Cost of sales 146,396 138,917 7,479 5%
Gross profit 158,001 179,729 (21,728) (12)%
Research and development 969 712 257 36%
Selling and administrative expenses 20,153 14,932 5,221 35%
Operating income 136,879 164,085 (27,206) (17)%
Other expense (income), net (354) (3,314) 2,960 (89)%
Related party Tax Receivable Agreement expense (benefit) 47 (3,346) 3,393 N/A
Interest expense 22,167 25,672 (3,505) (14)%
Interest income (37) (1,141) 1,104 (97)%
Income before provision for income taxes 115,056 146,214 (31,158) (21)%
Provision for income taxes 16,257 23,946 (7,689) (32)%
Net income $98,799 $122,268 $(23,469) (19)%

Net sales. Net sales decreased from $318.6 million in the three months ended March 31, 2020 to $304.4 million in the three months ended March 31, 2021. Lower net sales reflect decreased realized sales prices in the first quarter of 2021. This price decline reflects an increased percentage of non-LTA sales at prices lower than our LTA contracted prices as LTA deliveries have come down in accordance with the terms of the LTAs. Partially offsetting this impact was a 9% increase in sales volume due to the higher volume of non-LTA sales.

Cost of sales. We experienced an increase in cost of sales from $138.9 million in the three months ended March 31, 2020 to $146.4 million in the three months ended March 31, 2021, primarily due to the 9% increase in non-LTA sales volume of manufactured electrodes. Partially offsetting this increase was a per unit reduction of costs due to less usage of third-party needle coke.

Selling and administrative expenses. Selling and administrative expenses increased from $14.9 million in the three months ended March 31, 2020 to $20.2 million in the three months ended March 31, 2021 primarily due to higher legal costs and additions to the allowance for doubtful accounts.

Other expense (income), net. Other income decreased from $3.3 million in the three months ended March 31, 2020 to $0.4 million in the three months ended March 31, 2021, primarily due to advantageous non-cash foreign currency impacts on non-operating assets and liabilities in 2020 that did not recur in 2021.

Related party Tax Receivable Agreement expense (benefit). Related party Tax Receivable Agreement expense increased from a benefit of $3.3 million in the three months ended March 31, 2020 to an expense of $0.05 million in the three months ended March 31, 2021 due to a nonrecurring favorable adjustment that occurred in the first quarter of 2020.

Interest expense. Interest expense decreased from $25.7 million in the three months ended March 31, 2020 to $22.2 million in the three months ended March 31, 2021, primarily due to lower interest rates and lower average borrowings. During the three months ended March 31, 2021, we repriced our 2018 Term Loan Facility and reduced our term loan balance by an additional $150.0 million. These transactions resulted in $1.5 million of accelerated amortization of debt issuance costs and

$0.9 million of accelerated accretion of the original issue discount for the three months ended March 31, 2021. We also recorded $1.6 million of modification costs related to the term loan repricing.

Provision for income taxes. The following table summarizes the expense for income taxes:

(Dollars in thousands)

For the Three Months Ended March 31, 2021 2020
Tax expense $16,257 $23,946
Pretax income 115,056 146,214
Effective tax rates 14.1% 16.4%

The effective tax rate for the three months ended March 31, 2021 was 14.1%. This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at lower rates, the Section 250 Deduction and Foreign Tax Credits offset by the net increase related to the U.S. taxation of global intangible low taxed income ("GILTI").

The effective tax rate for the three months ended March 31, 2020 was 16.4%. This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates.

Tax expense decreased from $23.9 million for the three months ended March 31, 2020 to $16.3 million for the three months ended March 31, 2021. This change is primarily related to a reduction in pretax income, worldwide earnings from various countries taxed at different rates and the U.S. taxation of GILTI.

Effects of Changes in Currency Exchange Rates

When the currencies of non-U.S. countries in which we have a manufacturing facility decline (or increase) in value relative to the U.S. dollar, this has the effect of reducing (or increasing) the U.S. dollar equivalent cost of sales and other expenses with respect to those facilities. In certain countries in which we have manufacturing facilities, and in certain export markets, we sell in currencies other than the U.S. dollar. Accordingly, when these currencies increase (or decline) in value relative to the U.S. dollar, this has the effect of increasing (or reducing) net sales. The result of these effects is to increase (or decrease) operating profit and net income.

Many of the non-U.S. countries in which we have a manufacturing facility have been subject to significant economic and political changes, which have significantly impacted currency exchange rates. We cannot predict changes in currency exchange rates in the future or whether those changes will have net positive or negative impacts on our net sales, cost of sales or net income.

The impact of these changes in the average exchange rates of other currencies against the U.S. dollar on our net sales was an increase of $4.7 million for the three months ended March 31, 2021, compared to the same period of 2020. The impact of these changes on our cost of sales was an increase of $3.4 million for the three months ended March 31, 2021, compared to the same period of 2020.

We have in the past and may in the future use various financial instruments to manage certain exposures to risks caused by currency exchange rate changes, as described under “Part I, Item 3–Quantitative and Qualitative Disclosures about Market Risk.”

Liquidity and Capital Resources

Our sources of funds have consisted principally of cash flow from operations and debt, including our credit facilities (subject to continued compliance with the financial covenants and representations). Our uses of those funds (other than for operations) have consisted principally of dividends, capital expenditures, scheduled debt repayments, optional debt repayments, share repurchases and other obligations. Disruptions in the U.S. and international financial markets could adversely affect our liquidity and the cost and availability of financing to us in the future.

We believe that we have adequate liquidity to meet our needs. As of March 31, 2021, we had liquidity of $342.8 million, consisting of $246.4 million of availability under our 2018 Revolving Facility (subject to continued compliance with the financial covenants and representations) and cash and cash equivalents of $96.4 million. We had long-term debt of $1,273.0 million and short-term debt of $0.1 million as of March 31, 2021. As of December 31, 2020, we had liquidity of

$391.8 million consisting of $246.4 million available on our 2018 Revolving Facility (subject to continued compliance with the financial covenants and representations) and cash and cash equivalents of $145.4 million. We had long-term debt of $1,420.0 million and short-term debt of $0.1 million as of December 31, 2020.

As of March 31, 2021 and December 31, 2020, $91.4 million and $114.6 million, respectively, of our cash and cash equivalents were located outside of the U.S. We repatriate funds from our foreign subsidiaries through dividends. All of our subsidiaries face the customary statutory limitation that distributed dividends do not exceed the amount of retained and current earnings. In addition, for our subsidiary in South Africa, the South Africa Central Bank requires that certain solvency and liquidity ratios remain above defined levels after the dividend distribution, which historically has not materially affected our ability to repatriate cash from this jurisdiction. The cash and cash equivalents balances in South Africa were $1.8 million and $1.6 million as of March 31, 2021 and December 31, 2020, respectively. Upon repatriation to the U.S., the foreign source portion of dividends we receive from our foreign subsidiaries is no longer subject to U.S. federal income tax as a result of The Tax Cuts and Jobs Act.

Cash flow and plans to manage liquidity. Our cash flow typically fluctuates significantly between quarters due to various factors. These factors include customer order patterns, fluctuations in working capital requirements, timing of tax payments, timing of capital expenditures, acquisitions, divestitures and other factors. Cash flow from operations is expected to remain at positive sustained levels due to the predictable earnings generated by our three-to-five-year sales contracts with our customers.

Debt Structure

We had availability under the 2018 Revolving Facility of $246.4 million as of March 31, 2021 and December 31, 2020, which consisted of the $250 million limit reduced by $3.6 million of outstanding letters of credit.

On February 12, 2018, we entered into the 2018 Credit Agreement, which provides for the 2018 Revolving Facility and the 2018 Term Loan Facility ("2018 Term Loans"). On February 12, 2018, our wholly owned subsidiary, GrafTech Finance, borrowed $1,500 million under the 2018 Term Loan Facility.

On June 15, 2018, GrafTech entered into the First Amendment to its 2018 Credit Agreement. The First Amendment amends the 2018 Credit Agreement to provide for an additional $750 million in Incremental Term Loans principal outstanding under the promissory note. The Incremental Term Loans increase the aggregate principal amount of term loans incurred by GrafTech Finance under the 2018 Credit Agreement from $1,500 million to $2,250 million. The Incremental Term Loans have the same terms as those applicable to the existing term loans under the 2018 Credit Agreement, including interest rate, payment and prepayment terms, representations and warranties and covenants. The Incremental Term Loans mature on February 12, 2025, the same date as the existing term loans. GrafTech paid an upfront fee of 1.00% of the aggregate principal amount of the Incremental Term Loans on the effective date of the First Amendment. The current principal outstanding on our 2018 Term Loans is $794.0 million.

2020 Senior Notes

On December 22, 2020, GrafTech Finance issued $500 million aggregate principal amount of the 2020 Senior Notes at an issue price of 100% of the principal amount thereof in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act and to non-U.S. persons outside the United States under Regulation S under the Securities Act.

The 2020 Senior Notes were issued pursuant to the indenture among GrafTech Finance, as issuer, the Company, as a guarantor, the other subsidiaries of the Company named therein as guarantors and U.S. Bank National Association, as trustee and notes collateral agent.

The 2020 Senior Notes are guaranteed on a senior secured basis by the Company and all of its existing and future direct and indirect U.S. subsidiaries that guarantee, or borrow under, the credit facilities under its 2018 Credit Agreement . The 2020 Senior Notes are secured on a pari passu basis by the collateral securing the term loans under the 2018 Credit Agreement. GrafTech Finance, the Company and the other guarantors granted a security interest in such collateral, consisting of substantially all of their respective assets, as security for the obligations of GrafTech Finance, the Company and the other guarantors under the 2020 Senior Notes and the Indenture pursuant to a collateral agreement, dated as of December 22, 2020 (the “Collateral Agreement”), among GrafTech Finance, the Company, the other subsidiaries of the Company named therein as grantors and U.S. Bank National Association, as collateral agent.

The 2020 Senior Notes bear interest at the rate of 4.625% per annum, which accrues from December 22, 2020 and is payable in arrears on June 15 and December 15 of each year, commencing on June 15, 2021. The 2020 Senior Notes will mature on December 15, 2028, unless earlier redeemed or repurchased, and are subject to the terms and conditions set forth in the Indenture.

GrafTech Finance may redeem some or all of the 2020 Senior Notes at the redemption prices and on the terms specified in the Indenture. If the Company or GrafTech Finance experiences specific kinds of changes in control or the Company or any of its restricted subsidiaries sells certain of its assets, then GrafTech Finance must offer to repurchase the 2020 Senior Notes on the terms set forth in the Indenture.

The Indenture contains certain covenants that, among other things, limit the Company’s ability, and the ability of certain of its subsidiaries, to incur or guarantee additional indebtedness or issue preferred stock, pay distributions on, redeem or repurchase capital stock or redeem or repurchase subordinated debt, incur or suffer to exist liens securing indebtedness, make certain investments, engage in certain transactions with affiliates, consummate certain asset sales and effect a consolidation or merger, or sell, transfer, lease or otherwise dispose of all or substantially all assets. The Indenture contains events of default customary for agreements of its type (with customary grace periods, as applicable) and provides that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect to the Company or GrafTech Finance, all outstanding 2020 Senior Notes will become due and payable immediately without further action or notice. If any other type of event of default occurs and is continuing, then the trustee or the holders of at least 30% in principal amount of the then outstanding 2020 Senior Notes may declare all of the Senior Notes to be due and payable immediately.

The entirety of the 2020 Senior Notes proceeds was used to pay down a portion of our 2018 Term Loans.

2018 Term Loan Repricing

On February 17, 2021, the Company entered into a second amendment (the “Second Amendment”) to its 2018 Credit Agreement to, among other things, (a) decrease the Applicable Rate (as defined in the 2018 Credit Agreement) with respect to any 2018 Term Loans (as defined in the 2018 Credit Agreement) by 0.50% for each pricing level, (b) decrease the interest rate floor for all 2018 Term Loans to 0.50%, (c) add certain technical provisions with respect to the impact of European Union bail-in banking legislation on liabilities of certain non-U.S. financial institutions, and (d) add certain technical provisions in connection with future replacement of the LIBO Rate (as defined in the 2018 Credit Agreement). As a result of the Second Amendment and the combined effect of the reduction in the interest rate margin and the reduction in the interest rate floor, the interest rate on the 2018 Term Loans has been reduced by 1.0% per year.

In connection with the Second Amendment, on February 12, 2021, GrafTech Finance repaid approximately $150 million aggregate principal amount of its 2018 Term Loans with cash on hand.

Uses of Liquidity

On July 30, 2019, our Board of Directors authorized a program to repurchase up to $100 million of our outstanding common stock. We may purchase shares from time to time on the open market, including under Rule 10b5-1 and/or Rule 10b-18 plans. The amount and timing of repurchases are subject to a variety of factors including liquidity, stock price, applicable legal requirements, other business objectives and market conditions. We have repurchased 4,333,259 shares of common stock for a total purchase price of $41.0 million under this program since inception. There were no shares repurchased under this program during the three months ended March 31, 2021.

We currently pay a quarterly dividend of $0.01 per share or $0.04 on an annualized basis. We review our capital structure with the Board of Directors on an ongoing basis. There can be no assurance that we will pay dividends in the future in these amounts or at all. Our Board of Directors may change the timing and amount of any future dividend payments or eliminate the payment of future dividends in its sole discretion, without any prior notice to our stockholders. Our ability to pay dividends will depend upon many factors, including our financial position and liquidity, results of operations, legal requirements, restrictions that may be imposed by the terms of our current and future credit facilities and other debt obligations and other factors deemed relevant by our Board of Directors.

During 2020, we reduced our long-term debt principal by $400 million. During the three months ended March 31, 2021, we repaid an additional $150 million of principal of our 2018 Term Loans. We continue to prioritize balance sheet flexibility and debt repayment. We anticipate using a majority of the cash flow that we generate to repay debt, but we will continue to examine opportunities to repurchase our common stock.

Potential uses of our liquidity include dividends, share repurchases, capital expenditures, acquisitions, scheduled debt repayments, optional debt repayments, compensation-related Change in Control payments and other general purposes. An improving economy, while resulting in improved results of operations, could increase our cash requirements to purchase inventories, make capital expenditures and fund payables and other obligations until increased accounts receivable are converted into cash. A downturn, including the current downturn caused by the COVID-19 pandemic, could significantly and negatively impact our results of operations and cash flows, which, coupled with increased borrowings, could negatively impact our credit ratings, our ability to comply with debt covenants, our ability to secure additional financing and the cost of such financing, if available.

In order to seek to minimize our credit risks, we may reduce our sales of, or refuse to sell (except for prepayment, cash on delivery or under letters of credit or parent guarantees), our products to some customers and potential customers. Our unrecovered trade receivables worldwide have not been material during the last two years individually or in the aggregate.

We manage our capital expenditures by taking into account quality, plant reliability, safety, environmental and regulatory requirements, prudent or essential maintenance requirements, global economic conditions, available capital resources, liquidity, long-term business strategy and return on invested capital for the relevant expenditures, cost of capital and return on invested capital of the Company as a whole and other factors.

The Company's long-term incentive plan ("LTIP") contains a Change in Control provision requiring a payout of the plan upon Brookfield's ownership of the Company's common stock falling below 30%. Brookfield currently owns approximately 36.6% of our outstanding shares of common stock. The estimated range of the cash payout is $65 million to $75 million if and when a Change in Control actually occurs. For further information related to LTIP, see Note 7 "Contingencies" to the Notes to Condensed Consolidated Financial Statements.

Capital expenditures totaled $14.2 million in the three months ended March 31, 2021. We are managing inventory levels to match demand.

In the event that operating cash flows fail to provide sufficient liquidity to meet our business needs, including capital expenditures, any such shortfall would need to be made up by increased borrowings under our 2018 Revolving Facility, to the extent available.

Cash Flows

The following table summarizes our cash flow activities:

(in millions)

Cash flow provided by (used in): For the Three Months Ended March 31, 2021 2020
Operating activities $122.4 $139.3
Investing activities $(14.0) $(13.8)
Financing activities $(156.8) $(53.0)

Operating Activities

Cash flow from operating activities represents cash receipts and cash disbursements related to all of our activities other than investing and financing activities. Operating cash flow is derived by adjusting net income (loss) for:

  • Non-cash items such as depreciation and amortization, impairment, post retirement obligations, and severance and pension plan changes;
  • Gains and losses attributed to investing and financing activities such as gains and losses on the sale of assets and unrealized currency transaction gains and losses; and
  • Changes in operating assets and liabilities, which reflect timing differences between the receipt and payment of cash associated with transactions and when they are recognized in results of operations.

The net impact of the changes in working capital (operating assets and liabilities), which are discussed in more detail below, include the impact of changes in: receivables, inventories, prepaid expenses, accounts payable, accrued liabilities, accrued taxes, interest payable and payments of other current liabilities.

During the three months ended March 31, 2021, changes in working capital resulted in a net source of funds of $25.2 million, which was impacted by:

  • net cash outflows in accounts receivable of $16.6 million from the increase in accounts receivable due to the timing of sales;
  • net cash inflows due to decreased inventory of $11.6 million resulting from lower costs and sales outpacing production;
  • net cash outflows from decreased income taxes payable of $18.4 million resulting from tax payments, partially offset by 2021 income tax accruals;
  • net cash inflows from increases in accounts payable and accruals of $44.3 million, due to increased deferred revenue liabilities related to customer prepayments; and
  • net cash inflows of $5.7 million from increased interest payable due to interest accruing on our 2020 Senior Notes which will be paid semi-annually.

Uses of cash in the three months ended March 31, 2021 included contributions to pension and other benefit plans of $1.3 million, cash paid for interest of $11.6 million, payments under our tax receivable agreement, dated April 23, 2018 ("TRA") of $21.8 million and taxes paid of $35.8 million.

During the three months ended March 31, 2020, changes in working capital resulted in a net use of funds of $27.7 million, which was impacted by:

  • net cash inflows in accounts receivable of $40.7 million from the decrease in accounts receivable due to lower sales;
  • net cash outflows from increases in inventory of $17.2 million, due primarily to higher quantities of decant oil on hand;
  • net cash inflows of $7.4 million from the decrease in other current assets primarily due to value-added tax refunds received from foreign governments;
  • net cash inflows from increased income taxes payable of $14.2 million resulting from our ability to defer a $50.0 million tax payment in a foreign jurisdiction resulting from government enacted COVID-19 relief, partially offset by lower required tax payments due to lower profitability; and
  • net cash outflows from decreases in accounts payable and accruals of $17.4 million, due to lower purchases of third-party needle coke.

Uses of cash in the three months ended March 31, 2020 included contributions to pension and other benefit plans of $0.7 million, cash paid for interest of $24.1 million, payments under our TRA of $27.9 million and taxes paid of $2.3 million.

Investing Activities

Net cash used in investing activities was $14.0 million during the three months ended March 31, 2021, resulting from capital expenditures.

Net cash used in investing activities was $13.8 million during the three months ended March 31, 2020, resulting from capital expenditures.

Financing Activities

Net cash outflow from financing activities was $156.8 million during the three months ended March 31, 2021, which was the result of the repayment of $150.0 million of principal on our 2018 Term Loan Facility, $1.6 million of debt modification costs from our term loan repricing, $1.4 million of debt issuance costs from our 2020 Senior Note Issuance and $2.7 million of total dividends to stockholders.

Net cash outflow from financing activities was $53.0 million during the three months ended March 31, 2020, which was the result of $22.9 million of total dividends to stockholders and $30.1 million of stock repurchases.

Related Party Transactions

We have engaged in transactions with affiliates or related parties during 2021 and we expect to continue to do so in the future. These transactions include ongoing obligations under the TRA, Stockholders Rights Agreement and Registration Rights Agreement, each with Brookfield.

Recent Accounting Pronouncements

We discuss recently adopted accounting standards in Note 1, "Organization and Summary of Significant Accounting Policies" of the Notes to Condensed Consolidated Financial Statements.

Description of Our Financing Structure

We discuss our financing structure in more detail in Note 4, "Debt and Liquidity" of the Notes to Condensed Consolidated Financial Statements.

Market risk

As filed, 5,277 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risks, primarily from changes in interest rates, currency exchange rates, energy commodity prices and commercial energy rates. From time to time, we enter into transactions that have been authorized according to documented policies and procedures in order to manage these risks. These transactions primarily relate to financial instruments described below. Since the counterparties to these financial instruments are large commercial banks and similar financial institutions, we do not believe that we are exposed to material counterparty credit risk. We do not use financial instruments for trading purposes.

Our exposure to changes in interest rates results primarily from floating rate long-term debt tied to LIBO Rate or Euro LIBO Rate.

Our exposure to changes in currency exchange rates results primarily from:

  • sales made by our subsidiaries in currencies other than local currencies;
  • raw material purchases made by our foreign subsidiaries in currencies other than local currencies; and
  • investments in and intercompany loans to our foreign subsidiaries and our share of the earnings of those subsidiaries, to the extent denominated in currencies other than the U.S. dollar.

Our exposure to changes in energy commodity prices and commercial energy rates results primarily from the purchase or sale of refined oil products and the purchase of natural gas and electricity for use in our manufacturing operations.

Interest rate risk management. We periodically enter into agreements with financial institutions that are intended to limit our exposure to additional interest expense due to increases in variable interest rates. These instruments effectively cap our interest rate exposure. In 2019, we entered into four interest rate swap contracts and in 2021 we modified three contracts and closed one contract. As of March 31, 2021 we recorded an unrealized pre-tax gain of $2.4 million and a net unrealized pre-tax loss of $11.9 million as of December 31, 2020. Additionally, the modified swaps are considered hybrid instruments composed of a debt host and an embedded derivative. As of March 31, 2021, the debt host portion amounted to a pre-tax loss of $9.5 million, which will be amortized over the remaining life of the swaps.

Currency rate management. We enter into foreign currency derivatives from time to time to attempt to manage exposure to changes in currency exchange rates. These foreign currency derivatives, which include, but are not limited to, forward exchange contracts and purchased currency options, attempt to hedge global currency exposures. Forward exchange contracts are agreements to exchange different currencies at a specified future date and at a specified rate. Purchased currency options are instruments which give the holder the right, but not the obligation, to exchange different currencies at a specified rate at a specified date or over a range of specified dates. Forward exchange contracts and purchased currency options are carried at fair value.

The outstanding foreign currency derivatives represented $0.3 million pre-tax net loss as of March 31, 2021 and a net pre-tax loss of $0.1 million as of December 31, 2020.

Energy commodity management. We have entered into commodity derivative contracts to effectively fix some or all of our exposure to refined oil products. The outstanding commodity derivative contracts represented a net unrealized gain of $6.2 million and a net unrealized loss of $2.2 million as of March 31, 2021 and December 31, 2020, respectively.

Sensitivity analysis. We use sensitivity analysis to quantify potential impacts that market rate changes may have on the underlying exposures as well as on the fair values of our derivatives. The sensitivity analysis for the derivatives represents the hypothetical changes in value of the hedge position and does not reflect the related gain or loss on the forecasted underlying transaction.

A hypothetical increase in interest rates of 100 basis points (1%) would have increased our interest expense by $0.1 million, net of the impact of our interest rate swap, for the three months ended March 31, 2021. The same 100 basis points increase would have resulted in an increase of $13.6 million in the fair value of our interest rate swap portfolio.

As of March 31, 2021, a 10% appreciation or depreciation in the value of the U.S. dollar against foreign currencies from the prevailing market rates would have resulted in a corresponding decrease of $3.8 million or a corresponding increase of $3.8 million, respectively, in the fair value of the foreign currency hedge portfolio.

A 10% increase or decrease in the value of the underlying commodity prices that we hedge would have resulted in a corresponding increase or decrease of $4.8 million in the fair value of the commodity hedge portfolio as of March 31, 2021. Because of the high correlation between the hedging instrument and the underlying exposure, fluctuations in the value of the instruments are generally offset by reciprocal changes in the value of the underlying exposure.

For further information related to the financial instruments described above, see Note 9 "Derivative Instruments" to the Notes to Condensed Consolidated Financial Statements.

Controls and procedures

As filed, 1,762 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures. Management is responsible for establishing and maintaining adequate disclosure controls and procedures at the reasonable assurance level. Disclosure controls and procedures are designed at the reasonable assurance level to ensure that information required to be disclosed by a reporting company in the reports that it files or submits under Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by it in the reports that it files under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2021. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these controls and procedures were effective at the reasonable assurance level as of March 31, 2021.

Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting that occurred during the three months ended March 31, 2021 that materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Risk factors

As filed, 143 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to the Risk Factors disclosed in Part I- Item 1A of our Annual Report on Form 10-K filed February 23, 2021.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$304.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-01-01 to 2021-03-31$146.4mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-01-01 to 2021-03-31$158.0mus-gaap:GrossProfit
Research and development3 months2021-01-01 to 2021-03-31$969.0kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-01-01 to 2021-03-31$20.2mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-01-01 to 2021-03-31$136.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-01-01 to 2021-03-31$22.2mus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31$16.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31$98.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31$0.37us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-01-01 to 2021-03-31$0.37us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-01-01 to 2021-03-31267,465,319 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-01-01 to 2021-03-31$122.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$14.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2021-01-01 to 2021-03-31$1.4mus-gaap:PaymentsOfDividends
Share repurchases3 months2021-01-01 to 2021-03-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2021-03-31$96.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$583.7mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$1.38bnus-gaap:Assets
Current liabilitiesAt period end2021-03-31$203.5mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2021-03-31$1.27bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-03-31$127.0kus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2021-03-31$127.0kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2021-03-31−$233.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000931148-21-000091. Last ingested by Listed: Nov 10, 2026, 00:15 ET. Listed shows no prices and gives no investment advice.